• 1
    Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1998. CA Cancer J Clin 1998; 48: 629.
  • 2
    Gallup DG, Stock RJ: Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984; 64: 417420.
  • 3
    Whitaker GK, Lee RB, Benson WL: Carcinoma of the endometrium in young women. Mil Med 1986; 151: 2531.
  • 4
    Elwood JM, Boyes DA: Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens. Gynecol Oncol 1980; 10: 173187.
  • 5
    Killackey MA, Hakes TB, Pierce VK: Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 1985; 69: 237238.
  • 6
    Fornander T, Rutqvist LE, Cedermark B, et al: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1989; 21: 117120.
  • 7
    Fisher B, Costantino JP, Redmond CK, et al: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994; 86: 527537.
  • 8
    FIGO: Classification and staging of malignant tumors in the female pelvis. Int J Gynaecol Obstet 1971; 9: 172.
  • 9
    FIGO: Corpus cancer staging. Int J Gynaecol Obstet 1989; 28: 190.
  • 10
    Creasman WT, Morrow CP, Bundy BN, et al: Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group study. Cancer 1987; 60 (Suppl 8): 20352044.
  • 11
    Morrow CP, Bundy BN, Kurman RJ, et al: Relationship between surgical-pathological risk factors and outcome in clinical stages I and II carcinoma of the endometrium. A Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 5565.
  • 12
    Saint Cassia LJ, Weppelmann B, Shingleton H, et al: Management of early endometrial carcinoma. Gynecol Oncol 1989; 35: 362366.
  • 13
    Potish RA, Twiggs LB, Adcock LL, et al: Paraaortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol 1985; 654: 251256.
  • 14
    Malviya VK, Deppe G, Malone JM Jr, et al: Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. Gynecol Oncol 1989; 34: 299304.
  • 15
    Doering DL, Barnhill DR, Weiser EB, et al: Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol 1989; 74: 930933.
  • 16
    Childers JM, Brzechffa PR, Hatch KD, et al: Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol Oncol 1993; 51: 3338.
  • 17
    Boike G, Lurain J, Burke J: A comparison of laparoscopic management of endometrial cancer with a traditional laparotomy. Gynecol Oncol 1994; 52: 105. Abstract.
  • 18
    Childers JM, Hatch KD, Tran AN, et al: Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. Obstet Gynecol 1993; 82: 741747.
  • 19
    Aalders J, Abeler V, Kolstad P, et al: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419427.
  • 20
    Roberts JA, Brunetto VL, Keys HM, et al: A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial carcinoma (GOG 99). Proceedings of the Society of Gynecologic Oncologists Annual Meeting, 1998: 70. Abstract.
  • 21
    Aalders JG, Abeler V, Kolstad P: Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients. Gynecol Oncol 1984; 17: 85103.
  • 22
    Kuten A, Grigsby PW, Perez CA, et al: Results of radiotherapy in recurrent endometrial carcinoma: A retrospective analysis of 51 patients. Int J Radiat Oncol Biol Phys 1989; 17: 2934.
  • 23
    Kauppila A, Janne O, Kujansuu E, et al: Treatment of advanced endometrial adenocarcinoma with a combined cytotoxic therapy: Predictive value of cytosol estrogen and progestin receptor levels. Cancer 1980; 46: 21622167.
  • 24
    Thigpen T, Blessing J, Homesley H, et al: Phase III trial of doxorubicin +/- cisplatin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) study. Proceedings of American Society of Clinical Oncology 1993; 12: 261. Abstract.
  • 25
    Ball H, Blessing JA, Lentz S, et al: A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1996; 62: 278281.
  • 26
    Barnhill D, O'Connor D, Farley J, et al: Clinical surveillance of gynecologic cancer patients. Gynecol Oncol 1992; 46: 275280.
  • 27
    Podczaski E, Kaminski P, Gurski K, et al: Detection and patterns of treatment failure in 300 consecutive cases of “early” endometrial cancer after primary surgery. Gynecol Oncol 1992; 47: 323327.
  • 28
    Shumsky AG, Stuart GC, Brasher PM, et al: An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 1994; 55: 229233.
  • 29
    Berchuck A, Anspach C, Evans AC, et al: Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol 1995; 59: 2024.
  • 30
    Reddoch JM, Burke TW, Morris M, et al: Surveillance for recurrent endometrial carcinoma: Development of a follow-up scheme. Gynecol Oncol 1995; 59: 221225.
  • 31
    Rose PG, Sommers RM, Reale FR, et al: Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma. Obstet Gynecol 1994; 84: 1216.
  • 32
    Creasman WT, Henderson D, Hinshaw W, et al: Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 1986; 67: 326330.
  • 33
    Lee RB, Burke TW, Park RC: Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 1990; 36: 189191.
  • 34
    Chapman JA, DiSaia PJ, Osann K, et al: Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 1996; 175: 11951200.
  • 35
    Barakat RR, Park RC, Grigsby PW, et al: Corpus: Epithelial tumors, in HoskinsWJ, PerezCA, YoungRC (eds): Principles and Practice of Gynecologic Oncology, ed 2. Philadelphia, Lippincott-Raven Publishers, 1997, pp 859896.